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OBJECTIVES The study was done to test the ability to predict the extent of angiographically determined
coronary artery disease (CAD) by quantification of coronary calcium using electron-beam
computed tomography (EBCT) and to compare it with more conventional parameters for
delineating the angiographic extent of CAD, that is, cardiovascular risk factors and
radionuclide single-photon emission computed tomography (SPECT).
BACKGROUND The angiographic extent of CAD is a powerful predictor of subsequent events. Use of EBCT
may be able to define it by virtue of its ability to determine plaque burden.
METHODS We examined 308 patients presenting with suspected but not previously known CAD who
underwent selective coronary angiography. As measures of the angiographic extent of CAD,
coronary artery greater even 20 (CAGE $20) and CAGE $50 scores represented the total
number of coronary segments with $20% or $50% stenoses, respectively. The EBCT-
derived total calcium scores were obtained in 291 patients, risk factors as defined by the
National Cholesterol Education Program in 239 patients, and SPECT scans in 136 patients.
RESULTS Using multiple linear regression analysis, total calcium scores were better independent
predictors of both CAGE $20 and CAGE $50 scores than either a SPECT-derived
radionuclide perfusion score or the risk factors age, male gender and ratio of total/high-
density lipoprotein (HDL) cholesterol. The association between EBCT and angiographic
scores remained highly significant after excluding the influence of all interrelated risk factors
and SPECT variables (r 5 0.65; p , 0.001 for CAGE $20 scores, r 5 0.50; p , 0.001 for
CAGE $50 scores).
CONCLUSIONS Coronary calcium predicts the angiographic extent of CAD in symptomatic patients and
provides independent and incremental information to the more conventional clinical parameters
derived from SPECT or risk assessment. (J Am Coll Cardiol 1999;34:777–86) © 1999 by the
American College of Cardiology
Selective coronary angiography represents the current stan-
dard for the definition of coronary artery anatomy and
extent of coronary artery disease (CAD). The value of
noninvasive techniques used to examine patients with chest
pain and no known CAD is usually defined with respect to
the angiographically identified culprit lesion (or “maximum
stenosis”) as the reference standard. We have recently
reported that cutpoints of coronary artery calcium quantities
determined by electron-beam computed tomography
(EBCT) can be used to predict angiographic culprit stenosis
severity (1). In contrast, it has been suggested, given normal
ventricular geometry and function, that the anatomic extent
of angiographic disease may be a more important determi-
nant of morbidity and mortality than culprit lesion severity
(2–4). In fact, the angiographic worst stenosis is frequently
not the site of subsequent plaque rupture and thrombosis
(5,6).
Coronary artery calcium quantities are more closely re-
lated to mural atherosclerotic plaque burden than to coro-
nary luminal narrowing (7–9) and may therefore measure
more accurately the extent of coronary angiographic disease
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rather than providing information on maximum stenosis
severity. In this regard, EBCT would only be valuable in
providing information that adds to currently widely avail-
able clinical tests such as cardiac risk assessment and
radionuclide single-photon emission computed tomography
(SPECT) scanning. This has not been examined in a large
clinical population of patients presenting with suspected but
not previously known CAD.
METHODS
General outline. We determined the angiographic extent
of CAD in 308 patients by methods adopted by the
Coronary Artery Surgery Study (CASS) (10,11) and the
Bypass Angioplasty Revascularization Investigation (BARI)
(12,13) investigators. Twenty-seven coronary segments
were defined (including right or left dominance and the
presence of a ramus intermedius), providing for a complete
description of coronary angiographic anatomy.
We examined EBCT-derived coronary artery calcium for
predicting the total number of coronary segments with
stenoses $50% (“obstructive stenoses”) or $20% (“nonob-
structive and obstructive stenoses”) luminal diameter nar-
rowing, respectively. To analyze the comparative value of
EBCT in this respect, established clinical measures of risk
or extent of CAD, assessed by cardiac risk profiles as defined
by the National Cholesterol Education Program (NCEP)
(14) and radionuclide SPECT scans available in a subset of
patients, were also related to the angiographic extent of
disease.
Patients. The research protocol was approved by the Mayo
Clinic Institutional Review Board. Patient recruitment was
done during selected times depending on availability of the
EBCT scanner and a study coordinator. In these time
intervals, consecutive patients who underwent diagnostic
coronary angiography for clinical indications were invited to
participate in the research protocol if they had no previous
arteriographic documentation or invasive treatment of
CAD. Also, no patient had unstable angina or underwent
angioplasty at the time of angiography.
After signed informed consent, EBCT scanning was
performed on an average of one day following arteriography.
The original sample consisted of 339 patients. Results from
subsets of this patient population have been published
previously (1,15–17). These studies focused on the detection
of any angiographically obstructive stenoses or nonobstruc-
tive disease (15,16), on epidemiologic aspects of the distri-
bution of coronary calcium in different populations (17) and
on the use of different calcium quantity cutpoints for
defining the likely severity of angiographic stenoses (1).
Thirty-one patients were excluded from the present analysis
because they had a clinical diagnosis of prior myocardial
infarction or signs of ischemia in the resting electrocardio-
gram (ECG). In the remaining 308 patients, the most
common indication for coronary angiography was chest pain
(typical or atypical angina) in 216 patients (70%). Forty-
three patients (14%) had abnormal conventional stress tests,
23 (8%) had unexplained exertional dyspnea, 19 (6%) were
examined preoperatively (usually for valvular heart disease),
6 (2%) had congestive heart failure and 1 was examined for
a disability claim. The EBCT scans analyzed as described
below were available for 291 participants. The other partic-
ipants, having agreed to participate in the study, did not
undergo the EBCT examination owing to scheduling con-
flicts or unavailability of the scanner.
Coronary angiography. Coronary angiography was per-
formed by the Judkins technique with a minimum of five
views of the left system and two views of the right system.
The angiograms were analyzed on the basis of the coronary
segmental classification proposed by the CASS investigators
(10,11). The maximum percent diameter stenosis in any of
the 27 coronary segments was visually assessed by two
experienced angiographers unaware of the results of EBCT
scanning. Segments were defined as containing no or trivial
stenoses (0% to ,20%), stenoses ranging from 20% through
49% (nonobstructive disease) or ranging from 50% to 100%
(obstructive disease). In the case of a disagreement in the
interpretation of a given angiogram, there was arbitration
with the help of a third angiographer, as described previ-
ously (1).
The angiographic extent of CAD has been determined in
various ways. The most widely published method reflects
the extent of potentially flow-limiting luminal narrowing
($50% luminal diameter narrowing) and has been called the
“coronary artery greater even than 50 (CAGE $50) score”
by the CASS investigators (10,11). We replicated this
CAGE $50 score by generating the total number of
segments with a 50% or greater maximum stenosis per
patient. In view of recent reports on clinical events caused by
angiographically nonobstructive coronary lesions (5,6), we
reasoned that it was necessary to also include lesser narrow-
Abbreviations and Acronyms
BARI 5 Bypass Angioplasty
Revascularization Investigation
CAD 5 coronary artery disease
CAGE $20 score 5 coronary artery greater even than
20 score
CAGE $50 score 5 coronary artery greater even than
50 score
CASS 5 Coronary Artery Surgery Study
CT 5 computerized tomography
EBCT 5 electron-beam computed
tomography
ECC 5 electrocardiogram
HDL 5 high-density lipoprotein
LDL 5 low-density lipoprotein
NCEP 5 National Cholesterol Education
Program
SPECT 5 single-photon emission computed
tomography
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ings in a score that would better reflect the overall extent of
angiographically detectable CAD. By analogy, we created a
“CAGE $20 score” to represent the extent of reliably
identifiable nonobstructive and obstructive disease. The
total number of segments with a 20% or greater maximum
stenosis was the CAGE $20 score.
Electron-beam computed tomography. High-resolution,
noncontrast enhanced EBCT examinations (Imatron
C-100 scanner, Imatron, South San Francisco, California)
were performed in a manner described previously (1,16). In
all participants, 40 contiguous, 3-mm thick, transaxial
images were done commencing at the root of the aorta and
proceeding caudad through the apex of the heart. For each
study, a calcium score was determined using the methods of
Agatston and colleagues (18). This algorithm has been
widely used in research and clinical studies. The calcium
score is the product of the area of coronary artery calcium (at
least 2 contiguous pixels with a computed tomography [CT]
density $130 Hounsfield units) and a factor rated 1 through
4 dictated by the maximum CT density within that lesion.
A calcium score was calculated for each of the major
coronary arteries (left main, left anterior descending, left
circumflex and right coronary arteries) and the entire epi-
cardial coronary system (“total calcium score”). All EBCT
scans were read without knowledge of the results of the
patient’s risk factors (except, obviously, age and gender),
radionuclide scan results and angiographic findings.
Cardiac risk factors. Cardiac risk factors have been shown
previously to predict the extent of angiographic disease, that
is, CAGE $50 scores (10). To compare the associations of
risk factors against coronary calcium scores with CAGE
$20 or CAGE $50 scores, we used the current NCEP
definitions (14), taking into account age/gender (men $45
years, women $55 years), family history of CAD, current
cigarette smoking, hypertension (systolic or diastolic blood
pressure values $140 mm Hg and $90 mm Hg, respec-
tively, or antihypertensive treatment or both), low high-
density lipoprotein (HDL) cholesterol (,35 mg/dl), diabe-
tes mellitus and, as a negative risk factor, high HDL
cholesterol ($60 mg/dl). These risk factors were defined
precisely as outlined by the NCEP except for “family
history.” For this variable, “positive” information such as
definite myocardial infarction or sudden death in parents or
first-degree relatives up to age 75 for both genders was used.
No patients were taking lipid-lowering medications at the
time of study entry. In 250 patients, a lipoprotein analysis of
fasting total cholesterol, HDL cholesterol and triglycerides
was performed. Eleven patients had triglycerides $400 mg/dl.
Hence, calculations of low-density lipoprotein (LDL) cho-
lesterol levels as proposed by the NCEP were possible in
239 patients, who were accordingly classified into four risk
groups, with increasing probabilities of future cardiac events
from group 1 to 4 (14,19).
Treadmill exercise testing. Stress testing within three
months before coronary angiography was performed in 164
patients (53%). Of these patients, 90 (55%) had a test
judged to be unremarkable (n 5 49) or nondiagnostic (n 5
41), whereas 74 (45%) had a test positive for ischemia. After
exclusion of nondiagnostic tests, there was a significant
difference in CAGE $50 scores between tests positive for
ischemia and unremarkable tests (1.53 6 1.91 vs. 2.99 6 2.71;
p 5 0.001). However, this association was weaker than that
between radionuclide perfusion studies (see below) and CAGE
$50 scores. Indeed, in multivariate analysis, treadmill exercise
testing did not remain in a model assessing its predictive value
compared with radionuclide perfusion testing with regard to
CAGE $50 scores. To use the “best” conventional test in
comparison with EBCT, and because treadmill exercise testing
is not an established method for analyzing the extent of
angiographic disease, we decided to analyze radionuclide per-
fusion rather than treadmill exercise testing.
Radionuclide studies. An association between radionu-
clide SPECT perfusion studies and the extent of angio-
graphic CAD is well established (20). In a subset of patients
in which studies were available, we used SPECT as an
established noninvasive imaging modality for CAD extent
against which EBCT-derived coronary calcium scores could
be compared. The SPECT studies were performed before
coronary angiography in 136 patients. In 111 patients, the
Naughton or Bruce protocols were used for treadmill
exercise testing as previously described (21,22). Exercise was
continued until standard end points were achieved (21).
In 25 patients, pharmacologic agents were used; adeno-
sine was used (0.14 mg/kg/min) in 15 patients and dipyr-
idamole (up to 0.84 mg/kg) in 10 patients. Patients were
injected with 3 mCi of thallium-201 (n 5 103) or 20 to
30 mCi of technetium-99 sestamibi (n 5 33) intravenously
during the last minute of exercise or pharmacologic provo-
cation. Tomographic imaging was accomplished using a
rotating gamma camera using the “step-and-shoot” method,
acquiring 30 images for 40 s each at 6° intervals over a 180°
arc. Short-axis images at the basal, midventricular and apical
level were divided into 14 segments as previously described
(12). Poststress radionuclide uptake was graded for each
segment on a scale of 0 to 4 by consensus of two experienced
observers. To obtain a score reflecting increasing severity of
regional reductions in post-stress radionuclide uptake, nor-
mal or increased uptake was graded “0,” mildly reduced
uptake “1,” moderately reduced uptake “2,” markedly re-
duced uptake “3,” and absent uptake “4.” Delayed images
(obtained 4 h after stress for thallium and 24 h for
sestamibi) were used to ascertain that segments with mild
hypoperfusion also in the delayed images were not scored as
reversible perfusion defects. The grading for all 14 segments
was summed to generate an overall “radionuclide perfusion
score” reflecting the extent (number of segments) and severity
(grading) of post-stress reversible hypoperfusion (20).
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Statistics. Statistical analyses were performed using the
SPSS software package (version 8.0, SPSS, Chicago, Illi-
nois). Values are reported as mean 6 SD. To account for
the nonnormal distribution of calcium scores, a loge {1 1}
transformation was made. Triglyceride and total cholesterol
values were also transformed to the (natural) logarithmic
scale. Proportions between categories were analyzed using a
chi-square test. To enable comparisons between calcium
scores, radionuclide perfusion scores and cardiac risk factors
against categories of the angiographic extent of disease in
these chi-square analyses, quartiles of the calcium and
radionuclide perfusion scores and the NCEP-defined risk
groups (14) were used. The contingency coefficient was
determined as a measure of the degree of association of the
classifications in the contingency table (23). The maximum
value of this coefficient is 1.
Multiple linear regression analysis was performed to
examine the independent relation of cardiac risk factors,
radionuclide perfusion scores and total calcium scores with
CAGE $20 and CAGE $50 scores, respectively. In this
case, mostly continuous variables were analyzed, and the
following cardiac risk factors were entered independently
into the model: age (years), gender (male/female), smoking
(never/former/active), hypertension (present/absent), diabe-
tes (present/absent), family history (present/absent), calcu-
lated LDL cholesterol (mg/dl) and triglycerides (mg/dl,
loge-transformed). Total cholesterol (mg/dl, loge-transformed)
and HDL cholesterol (mg/dl) were also entered or, alter-
natively, the ratio of total cholesterol/HDL cholesterol,
depending on the best predictive values achieved. Only
independently predictive risk factor variables were forced
into the regression models together with radionuclide per-
fusion and calcium scores.
Finally, we analyzed the partial correlation between total
calcium scores and CAGE $20 and CAGE $50 scores,
respectively, after exclusion of all interrelated co-factors that
might influence these relationships. This was done by
correlating the residuals of two regression models. These
residuals were the difference between individual predicted
values and the actually observed values. One model tested
the associations of individual risk factors and radionuclide
perfusion scores with CAGE $20 or CAGE $50 scores,
respectively, and the other model tested the associations of
individual risk factors and radionuclide perfusion scores
with total calcium scores. The residuals of these models
represented the part of information inherent in the angio-
graphic or calcium scores, respectively, independent from
the risk factor and radionuclide perfusion variables. Residual
values were negative for predicted values lower than ob-
served values and positive for predicted values greater than
observed values. Plotting these residuals against each other
then showed the association between calcium scores and
angiographic scores truly independent from any interrela-
tionships with risk factors or radionuclide perfusion vari-
ables. For all statistical evaluations, a value of two-tailed p ,
0.05 was considered significant.
RESULTS
Patient demographics. BASIC DEMOGRAPHICS. Basic pa-
tient demographics are given in Table 1. Left ventricular
ejection fraction was normal in most patients. There were
no statistical differences in any of the variables listed in
Table 1 in subgroups of patients who had complete risk factor
analysis and/or SPECT studies, indicating very comparable
demographics across these subgroups. Table 2 gives angio-
graphic characteristics. The median number of segments with
$20% maximum stenosis per patient (i.e., the median CAGE
$20 score) was 4 (the 25th and 75th percentiles were 2 and 7,
respectively). The median CAGE $50 score was 1 (the 25th
and 75th percentiles were 0 and 4, respectively). The numbers
of patients in each category of CAGE $20 and CAGE $50
scores are shown in Figure 1A and B, respectively.
ELECTRON-BEAM COMPUTED TOMOGRAPHY. Of the 291
patients with EBCT scans, 262 (90%) had a positive score
(i.e., a total calcium score .0). Positive total calcium scores
Table 1. Patient Demographics (n 5 308)
Mean 6 SD
(median; 25th, 75th percentiles)
No. of Patients
(%)
Age (yr) 55 6 11 (55; 48, 64)
Left ventricular ejection fraction* 0.64 6 0.13 (0.66; 0.56, 0.72)
Total cholesterol (mg/dl)† 219 6 50 (212; 191, 243)
HDL cholesterol (mg/dl)† 43 6 14 (40; 33, 49)
Ratio of total cholesterol/HDL cholesterol† 5.5 6 1.9 (5.4; 4.3, 6.4)
Triglycerides (mg/dl)* 186 6 139 (149; 100, 225)
Calculated LDL cholesterol (mg/dl)‡ 139 6 39 (135; 117, 161)
Male gender 240 (78)
Current smoking 73 (24)
Hypertension 140 (46)
Diabetes mellitus 43 (14)
Family history of coronary heart disease 154 (50)
*Cineangiographic measurements, available in 241 patients. †Available in 250 patients. ‡Calculation (Friedewald formula)
possible in 239 patients.
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ranged from 0.5 through 7,633. The mean and median
scores were 447 6 807 and 144, respectively. The 25th and
75th percentiles were 7.5 and 545, respectively.
CARDIAC RISK FACTORS. Individual risk factors are listed in
Table 1. Patient classification according to the risk groups
specified by the NCEP (14,19) resulted in a fairly homo-
geneous distribution of the 239 patients with available
lipoprotein values across the four risk groups. Eighty-seven
(36%) patients were in group 1, 27 (11%) in group 2, 62
(21%) in group 3 and 69 (22%) in group 4.
RADIONUCLIDE IMAGING. Of the 136 patients with radio-
nuclide stress imaging before coronary angiography, 112
(82%) had reversible reduced tracer uptake in at least one
segment. The radionuclide perfusion score in these patients
ranged from 1 through 34. The mean and median scores
were 8.6 6 8.0 and 6.0, respectively. The 25th and 75th
percentiles were 2.0 and 14.8.
Table 3 provides an overview of the results of total
calcium score quartiles, NCEP risk groups and radionuclide
perfusion score quartiles grouped as a function of CAGE
$20 or CAGE $50 scores. Chi-square analysis showed
significant correlations of total calcium scores and, to a
lesser degree, radionuclide perfusion scores with both
CAGE $20 and CAGE $50 scores. The NCEP risk
groups were significantly related to CAGE $20, but not
CAGE $50 scores.
Prediction of angiographic measures of disease. CALCIUM
SCORES VERSUS ANGIOGRAPHIC SCORES. The relationship
between loge-transformed total calcium scores and CAGE
$20 scores was best described by a quadratic (second-order
polynomial) function (r 5 0.77, Fig. 2A). The relationship
between loge-transformed total calcium scores and CAGE
$50 scores was characterized by a relatively flat first portion
of the curve, which then became exponential with increasing
extent of angiographic disease (Fig. 2B). This was again best
described by a quadratic function (r 5 0.68). The associa-
tion of total calcium scores was better with CAGE $20
than with CAGE $50 scores (z-statistic 5 2.30; p 5
0.022).
RISK FACTORS VERSUS ANGIOGRAPHIC SCORES. Indepen-
dent risk factor predictors of both CAGE $20 and CAGE
$50 scores were age, male gender, the ratio of total
Table 2. Angiographic Characteristics (n 5 308)
No. of
Patients (%)
CAGE >20 Score
Mean 6 SD
CAGE >50 Score
Mean 6 SD
Normal/near normal coronary arteries
(,20% luminal diameter stenosis)
59 (19) — —
Nonobstructive coronary artery disease
(20%–49% luminal diameter stenosis)
69 (22) 2.90 6 1.63 —
1-Vessel disease ($50% maximum
diameter stenosis)
47 (15) 4.62 6 2.24 1.36 6 0.74
2-Vessel disease ($50% maximum
diameter stenosis)
61 (20) 6.13 6 2.19 2.66 6 0.91
3-Vessel disease ($50% maximum
diameter stenosis)
72 (23) 8.87 6 2.41 5.94 6 2.06
Figure 1. (A) Absolute number of patients in each category of
CAGE $20 scores. (B) Absolute number of patients in each
category of CAGE $50 scores.
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cholesterol over HDL cholesterol and calculated LDL
cholesterol, respectively (Table 4). Stepwise linear regres-
sion analysis eliminated calculated LDL cholesterol from
both models.
RISK FACTORS AND RADIONUCLIDE PERFUSION SCORES
VERSUS ANGIOGRAPHIC SCORES. Radionuclide perfusion
scores (reducing the number of available observations to
118) were entered in addition to age, gender and the ratio
of total cholesterol/HDL cholesterol. Radionuclide per-
fusion scores were independently predictive of both
CAGE $20 and CAGE $50 scores, although the
previously mentioned risk factors retained their predictive
significance (Table 4).
RISK FACTORS, RADIONUCLIDE PERFUSION SCORES, AND
TOTAL CALCIUM SCORES VERSUS ANGIOGRAPHIC SCORES.
When total calcium scores were added to the model, only
age remained predictive of CAGE $20 scores besides total
calcium scores, and only radionuclide perfusion scores re-
mained predictive of CAGE $50 scores besides total
calcium scores (Table 4). The T-values, indicating the
degree of association, were about two times greater for total
calcium scores than for either age or radionuclide perfusion
scores. Figure 3 shows that after exclusion of all interre-
lated co-factors in this analysis—that is, after exclusion of
cardiac risk factors and radionuclide perfusion scores—
there was still a highly significant correlation between
total calcium scores and either CAGE $20 scores (r 5
0.65) or CAGE $50 scores (r 5 0.50; p 5 0.065 vs.
CAGE $20 scores).
DISCUSSION
As opposed to prior studies, the current investigation used
very detailed information on the angiographic extent of
CAD as the standard against which risk factors, SPECT
and EBCT were compared. It demonstrated in a clinical
population of symptomatic patients without documented
prior CAD that coronary calcium scores have independent
and incremental value for predicting the extent of any
(CAGE $20 score) or obstructive (CAGE $50 score)
angiographic CAD compared with cardiac risk factors or
radionuclide perfusion studies.
Angiographic measures of the extent of CAD. CAGE
$20 and CAGE $50 scores provide a comprehensive
representation of the coronary tree, describing the overall
number of coronary segments with any stenoses or poten-
tially flow-limiting stenoses, respectively. Although there is
a positive relation of maximum stenosis severity with
CAGE $20 and CAGE $50 scores, it is important to note
Table 3. Total Calcium Score Quartiles, NCEP Risk Groups and Radionuclide Imaging Score Quartiles as a Function of CAGE
$20 or CAGE $50 Scores
No. of Patients (%)
Angiographic Data EBCT Data Risk Factor Data SPECT Data
CAGE >20
Score Groups*
Total Calcium
Score Quartiles (a)
NCEP Risk
Groups (b)
Radionuclide Perfusion
Score Quartiles (c)
1 2 3 4 1 2 3 4 1 2 3 4
1 (0–1) 46 20 2 — 28 8 12 7 5 5 4 1
(16) (7) (1) (12) (3) (5) (3) (4) (4) (3) (1)
2 (2–4) 22 32 24 6 24 11 20 13 18 11 6 5
(8) (11) (8) (2) (10) (5) (8) (5) (13) (8) (4) (4)
3 (5–7) 4 18 30 25 21 3 17 23 11 8 10 11
(1) (6) (10) (9) (9) (1) (7) (10) (8) (6) (7) (8)
4 (8–15) 1 4 16 41 14 5 13 20 4 10 10 17
(0) (1) (6) (14) (6) (2) (5) (8) (3) (7) (7) (13)
CAGE >50
Score Groups* (d) (e) (f)
1 (0) 65 43 12 3 43 15 21 18 13 13 8 2
(22) (15) (4) (1) (18) (6) (9) (8) (10) (10) (6) (2)
2 (1) 6 10 14 4 6 3 7 8 8 2 4 5
(2) (3) (5) (1) (3) (1) (3) (3) (6) (2) (3) (4)
3 (2–3) — 12 28 19 20 3 18 12 14 10 3 11
(4) (10) (7) (8) (1) (8) (5) (10) (7) (2) (8)
4 (4–12) 2 9 18 46 18 6 16 25 3 9 15 16
(1) (3) (6) (16) (8) (3) (7) (11) (2) (7) (11) (12)
*The actual CAGE $20 and CAGE $50 scores are in parentheses. Group 1 of CAGE $50 scores comprises patients with no stenoses of 50% or greater (128 patients, 42%):
(a) x2 5 181.54, p , 0.0001, contingency coefficient 5 0.62; (b) x2 5 20.32, p 5 0.016, contingency coefficient 5 0.28; (c) x2 5 20.47, p 5 0.015, contingency coefficient 5 0.36;
(d) x2 5 175.04, p , 0.0001, contingency coefficient 5 0.61; (e) x2 5 15.89, p 5 0.07, contingency coefficient 5 0.25; (f) x2 5 28.68, p 5 0.0005, contingency coefficient 5 0.42.
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that these angiographic measures reflect distinctly different
aspects of angiographically assessed CAD (i.e., severity vs.
extent of angiographic CAD). Measures of the angiographic
extent of CAD used in clinical practice, such as the
number of major vessels with significant disease, appear
to have incremental prognostic value beyond the use of
maximum (“culprit”) stenosis severity alone (2,3,24,25).
The angiographic extent of disease has been established
as an important predictor of prognosis in prospective
investigations close to following the patient’s natural
history (2,25,26).
In addition, theoretical considerations suggest the impor-
tance of accounting for the extent of disease. Vulnerable
coronary plaques display variable angiographic characteris-
tics (27), and stenosis severity cannot be used to predict
subsequent events reliably (5,6). A greater amount of overall
plaque formation may be associated with a greater number
of individually vulnerable plaques (28). Finally, acute myo-
cardial infarction has been described as a result of multifo-
cal, “systemic” coronary disease activity (29).
Coronary calcium scores as a measure of the angio-
graphic extent of disease. The association of coronary
calcium scores with CAGE $20 scores was significantly
stronger than with CAGE $50 scores. Histopathologic
site-by-site comparisons have shown that the amount of
coronary artery calcium is related directly to atherosclerotic
plaque burden rather than directly to the degree of luminal
narrowing (7,9,30). Analysis of luminal narrowing by cor-
onary angiography tends to underestimate coronary athero-
sclerotic plaque burden. Because of various mechanisms
related to the angiographic technique itself (31) and the
pathogenesis of coronary atherosclerosis (31,32), obstructive
stenoses are often only visualized in patients with substantial
plaque burdens. Thus, CAGE $20 scores should be antic-
Figure 2. (A) Relation between CAGE $20 scores (Y-axis) and loge-transformed total calcium scores (X-axis). (B) Relation between
CAGE $50 scores (Y-axis) and loge-transformed total calcium scores (X-axis).
783JACC Vol. 34, No. 3, 1999 Schmermund et al.
September 1999:777–86 Coronary Calcium and Extent of Disease
ipated to reflect the overall extent of coronary atherosclero-
sis better than CAGE $50 scores.
EBCT calcium scores compared against risk factors and
radionuclide studies. The associations of total calcium
scores with both CAGE $20 and CAGE $50 scores
demonstrated incremental value compared to similar asso-
ciations with SPECT scanning and cardiac risk factors
(Table 4, Fig. 3). Of note, the NCEP-defined risk factors
have been identified as predictive of subsequent cardiac
events and not angiographic CAD. Of course, risk factors,
coronary atherosclerotic disease and future cardiac events
are interrelated (33). However, active smoking, for example,
although associated with future cardiac events, is in some
clinical settings associated with less angiographically mea-
sured CAD (11,34). In the current study, compared with
never- and former smokers (n 5 231), active smokers (n 5
73) had significantly lower CAGE $20 scores (3.95 vs.
4.92, p 5 0.04), CAGE $50 scores (1.53 vs. 2.31, p 5
0.01) and maximum percent stenosis (47% vs. 58%, p 5
0.03). Accordingly, this limits the use of NCEP-defined
risk factors for prediction of angiographic CAD, but not for
prediction of events associated with enhanced thromboge-
nicity or endothelial dysfunction, known factors associated
with active smoking.
Total EBCT calcium scores performed better than radio-
nuclide perfusion scores for both prediction of angiographic
CAGE $20 and CAGE $50 scores. Our study is consis-
tent with a previous report comparing quantification of
coronary artery calcium with exercise thallium SPECT for
the detection of angiographically significant CAD (35). The
SPECT scanning as performed in these studies has been
designed to identify the physiologic effects of (flow-
limiting) stenoses on myocardial perfusion. It seems only
consequential that in the current investigation, radionuclide
perfusion scores performed better for predicting CAGE
$50 than CAGE $20 scores (Table 3). In many ways,
radionuclide perfusion studies examine functional aspects of
the coronary circulation.
In addition to epicardial coronary luminal stenosis mor-
phology, severity and the number of stenoses, microvascular
disease or functional abnormalities of the coronary circula-
tion may affect myocardial radionuclide uptake (36). Coro-
nary calcium scores and risk factor assessment may then
provide information on underlying atherosclerotic plaque
burdens complementing the physiologic assessment of the
coronary circulation provided by SPECT imaging. It should
also be kept in mind that patients with unremarkable
SPECT studies were probably underrepresented owing to
the effect of referral bias in this angiographic population
(37).
Study limitations. Complete results of cardiac risk factor
analysis, SPECT perfusion imaging and EBCT coronary
calcium scores were only available in a subset of 118
patients. Our results in this limited number of patients,
however, were very consistent with the results in the overall
study population with respect to risk factor and coronary
calcium associations with the angiographic extent of CAD.
The general bias found in patient populations referred for
coronary angiography does not permit extrapolation of our
data to broader populations. The previously stated specific
referral bias pertaining to patients undergoing SPECT
imaging usually results in a decreased specificity for detec-
Table 4. Multiple Linear Regression Analysis to Determine Independent Predictors of the Number of Angiographic Segments with
20% or Greater Maximum Stenosis (CAGE $20 score) or 50% or Greater Maximum Stenosis (CAGE $50 score)
CAGE >20 Scores CAGE >50 Scores
C SE T P R2 C SE T P R2
Age (yr) 0.17 0.02 9.61 0.00 0.32 0.10 0.01 7.34 0.00 0.23
Male gender 1.94 0.47 4.15 0.00 1.40 0.36 3.92 0.00
Total/HDL cholesterol 0.25 0.12 2.20 0.03 0.16 0.09 1.81 0.05
LDL cholesterol (mg/dl, calculated) 0.01 0.01 2.20 0.03 0.01 0.00 1.99 0.05
Age (yr) 0.16 0.03 6.27 0.00 0.37 0.09 0.02 4.67 0.00 0.29
Male gender 1.75 0.66 2.64 0.01 1.25 0.50 2.48 0.02
Total/HDL cholesterol 0.38 0.15 2.54 0.01 0.25 0.11 2.20 0.03
Radionuclide perfusion score 0.12 0.03 3.42 0.00 0.09 0.03 3.56 0.00
Age (yr) 0.06 0.02 2.60 0.01 0.60 — — — 0.08 0.44
Male gender — — — 0.22 — — — 0.18
Total/HDL cholesterol — — — 0.08 — — — 0.13
Radionuclide perfusion score — — — 0.14 0.05 0.03 2.05 0.04
Total calcium score (loge-transformed) 0.88 0.11 7.85 0.00 0.50 0.10 5.26 0.00
Before entering the other variables into the regression model, the most important cardiac risk factor predictors were determined. Then, first radionuclide perfusion scores and
finally, EBCT calcium scores were added. T-values were derived from testing the null hypothesis that the independent variable (i.e., risk factors, radionuclide perfusion scores
or EBCT calcium scores) did not contribute to predicting the dependent variable (i.e., CAGE $20 or CAGE $50 scores). Large T-values can be interpreted as indicating a
true association between the independent and dependent variables. P-values were calculated as the probability of committing a type I error, based on T. Independent variables
can be interpreted as predicting the dependent variable when p , 0.05.
C 5 coefficient; HDL 5 high-density lipoprotein; LDL 5 low-density lipoprotein, SE 5 standard error.
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tion of flow-limiting stenoses in these patients. These
problems, common to most current clinical studies compar-
ing SPECT and coronary angiography, limit the potential
for comparisons between EBCT and SPECT. However,
because we did not analyze dichotomized data as dependent
variables, but rather, continuous angiographic scores, the
statistical effect of referral bias may have been less impor-
tant. Patients with established CAD (prior myocardial
infarction, unequivocal ECG or angiographic diagnosis)
were excluded from our study.
Both CAGE $50 and CAGE $20 scores are subject to
the considerable intra- and interobserver variability reported
in angiographic studies (38). The probability of systemic
errors was low, because the angiograms and the coronary
calcium scans were interpreted by blinded observers. More
importantly, even though requiring individual decisions as
to which stenoses are potentially flow-limiting, CAGE $50
scores have been successfully used (10,11). We do not
expect that reproducibility would be more of an issue for
CAGE $20 than for CAGE $50 scores, because CAGE
$20 scores only required decisions as to the presence of
readily identifiable stenoses in a given coronary segment.
Hence, stenoses were in the range from 20% through 100%,
whereas wall irregularities were not considered.
Clinical implications. Our results indicate that coronary
artery calcium quantities determined by EBCT predict the
angiographic extent of CAD in symptomatic patients,
providing independent and incremental information com-
pared with established cardiac risk factors and SPECT
imaging. In view of the unfavorable prognosis conveyed by
a greater extent of coronary disease (2,3,24–26), an estimate
of its extent may facilitate clinical decision making regard-
ing treatment options of varying aggressiveness.
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